Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.

Soto ME, van Kan GA, Nourhashemi F, Gillette-Guyonnet S, Cesari M, Cantet C, Rolland Y, Vellas B.

J Am Geriatr Soc. 2013 Sep;61(9):1482-8. doi: 10.1111/jgs.12415. Epub 2013 Sep 3.

PMID:
24000874
2.

Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease.

Soto ME, Secher M, Gillette-Guyonnet S, Abellan van Kan G, Andrieu S, Nourhashemi F, Rolland Y, Vellas B.

J Alzheimers Dis. 2012;28(3):647-54. doi: 10.3233/JAD-2011-110713.

PMID:
22045479
3.

Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study.

Onder G, Penninx BW, Balkrishnan R, Fried LP, Chaves PH, Williamson J, Carter C, Di Bari M, Guralnik JM, Pahor M.

Lancet. 2002 Mar 16;359(9310):926-30.

PMID:
11918911
4.

Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease.

O'Caoimh R, Healy L, Gao Y, Svendrovski A, Kerins DM, Eustace J, Kehoe PG, Guyatt G, Molloy DW.

J Alzheimers Dis. 2014;40(3):595-603. doi: 10.3233/JAD-131694.

PMID:
24496072
5.

Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.

Rozzini L, Chilovi BV, Bertoletti E, Conti M, Del Rio I, Trabucchi M, Padovani A.

Int J Geriatr Psychiatry. 2006 Jun;21(6):550-5.

PMID:
16642542
6.

Cardiovascular disease risk factors and progression of Alzheimer's disease.

Abellan van Kan G, Rolland Y, Nourhashémi F, Coley N, Andrieu S, Vellas B.

Dement Geriatr Cogn Disord. 2009;27(3):240-6. doi: 10.1159/000203365. Epub 2009 Feb 21.

PMID:
19246908
7.

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.

Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Goff DC Jr.

Arch Intern Med. 2009 Jul 13;169(13):1195-202. doi: 10.1001/archinternmed.2009.175.

8.

Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.

Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B; REAL.FR Study Group.

Neurology. 2009 Oct 27;73(17):1359-66. doi: 10.1212/WNL.0b013e3181bd80e9.

PMID:
19858457
9.

[Behavioral and psychologic symptoms in Alzheimer's disease: results of the REAL.FR study].

Benoit M, Staccini P, Brocker P, Benhamidat T, Bertogliati C, Lechowski L, Tortrat D, Robert PH.

Rev Med Interne. 2003 Oct;24 Suppl 3:319s-324s. French.

PMID:
14710451
10.

Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study.

Hajjar IM, Keown M, Lewis P, Almor A.

Am J Alzheimers Dis Other Demen. 2008 Feb-Mar;23(1):77-83. doi: 10.1177/1533317507309803.

PMID:
18276960
11.

Long-term progression of Alzheimer's disease in patients under antidementia drugs.

Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B; REAL.FR study group.

Alzheimers Dement. 2011 Nov;7(6):579-92. doi: 10.1016/j.jalz.2011.02.009.

PMID:
22055975
12.

[The benefit of angiotensin converting enzyme inhibitor for geriatric syndrome in the elderly].

Ebihara T, Ohrui T, Ebihara S, Tsuji I, Sasaki H, Arai H.

Nihon Ronen Igakkai Zasshi. 2007 Jul;44(4):448-51. Japanese.

13.
14.

Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

Wharton W, Goldstein FC, Zhao L, Steenland K, Levey AI, Hajjar I.

J Am Geriatr Soc. 2015 Sep;63(9):1749-56. doi: 10.1111/jgs.13627.

15.

[Vascular risk factors and Alzheimer's disease].

Voisin T, Lugardon S, Balardy L, Vellas B.

Rev Med Interne. 2003 Oct;24 Suppl 3:288s-291s. French.

PMID:
14710446
16.

Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.

Solfrizzi V, Scafato E, Frisardi V, Seripa D, Logroscino G, Kehoe PG, Imbimbo BP, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Pilotto A, Panza F; Italian Longitudinal Study on Aging Working Group.

Age (Dordr). 2013 Apr;35(2):441-53. doi: 10.1007/s11357-011-9360-z. Epub 2011 Dec 28.

17.

Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.

Handels RL, Xu W, Rizzuto D, Caracciolo B, Wang R, Winblad B, Verhey FR, Severens JL, Fratiglioni L, Joore MA, Wimo A.

J Alzheimers Dis. 2013;37(2):357-65. doi: 10.3233/JAD-130296.

PMID:
23948894
18.

The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women.

Yasar S, Zhou J, Varadhan R, Carlson MC.

Clin Pharmacol Ther. 2008 Jul;84(1):119-26. doi: 10.1038/sj.clpt.6100483. Epub 2008 Mar 19.

PMID:
18231116
19.

Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group).

Guerin O, Soto ME, Brocker P, Robert PH, Benoit M, Vellas B; REAL.FR Group.

J Nutr Health Aging. 2005;9(2):81-4.

PMID:
15791350
20.

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.

Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N.

Expert Rev Neurother. 2009 Sep;9(9):1413-31. doi: 10.1586/ern.09.89. Review.

PMID:
19769454
Items per page

Supplemental Content

Write to the Help Desk